111 studies found for:    Open Studies | "Warfarin"
Show Display Options
Rank Status Study
21 Recruiting Cost Effectiveness Analysis In Patients With Heart Valve Prosthesis
Condition: Complications Due to Heart Valve Prosthesis
Interventions: Drug: Acetyl Salicylic Acid;   Drug: Warfarin;   Drug: Placebo (for Aspirin)
22 Recruiting Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
Conditions: Atrial Fibrillation;   Percutaneous Coronary Intervention
Interventions: Drug: Dabigatran Etexilate 110mg;   Drug: Warfarin 3mg;   Drug: Aspirin;   Drug: Dabigatran Etexilate 150mg;   Drug: Clopidogrel or Ticagrelor;   Drug: Warfarin 5mg;   Drug: Warfarin 1mg
23 Recruiting Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque
Condition: Atrial Fibrillation
Interventions: Drug: apixaban;   Drug: warfarin
24 Recruiting Genotype-guided Warfarin Individualized Treatment
Conditions: Atrial Fibrillation;   Deep Venous Thrombosis
Interventions: Behavioral: Genotype-guided dosing algorithm for warfarin;   Behavioral: Standard initiation dose for warfarin
25 Recruiting Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT
Condition: Thromboembolism
Interventions: Genetic: Pharmacogenetic Warfarin Initiation;   Other: Clinical Warfarin Initiation
26 Unknown  A Trial of Genotype-based Warfarin Initiation in Patients With Mechanical Prosthetic Heart Valve
Conditions: Anticoagulation Treatment Overdose;   Heart Valve Diseases
Interventions: Other: Genotype-based Warfarin Initiation model;   Other: clinical factor-based warfarin initiation model
27 Recruiting Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)
Condition: Atrial Fibrillation
Interventions: Drug: Warfarin;   Drug: Dabigatran Etexilate 150mg
28 Not yet recruiting Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease
Conditions: Atrial Fibrillation;   Chronic Kidney Disease
Interventions: Drug: warfarin;   Drug: aspirin
29 Not yet recruiting RIvaroxaban for Valvular Heart diseasE and atRial Fibrillation Trial -RIVER Trial
Condition: Valvular Heart Disease
Interventions: Drug: Rivaroxaban;   Drug: Warfarin
30 Recruiting Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: edoxaban;   Drug: Enoxaparin;   Drug: Warfarin
31 Not yet recruiting Hemorrhage Following Small Polyp Resection in the Colon in Anticoagulated Patients
Conditions: Post Polypectomy Bleeding in Anticoagulated Patients;   Gastrointestinal Hemorrhage
Interventions: Drug: Warfarin;   Drug: LMW Heparin
32 Recruiting Use of Phytonadione to Reduce International Normalized Ratio (INR) Variability in Patients on Long-term Warfarin Therapy
Condition: Coagulation Delay
Interventions: Dietary Supplement: phytonadione;   Drug: none-control group
33 Recruiting Short Term Warfarin Therapy for Radiofrequency Catheter Ablation of Atrial Fibrillation
Condition: Atrial Fibrillation
Intervention: Drug: warfarin
34 Recruiting Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium
Condition: Atherosclerosis
Interventions: Drug: rivaroxaban;   Drug: Warfarin
35 Not yet recruiting Statin Use in Patients With Acute VTE
Condition: Venous Thromboembolism
Interventions: Drug: Atorvastatin;   Drug: Warfarin
36 Recruiting Evaluation of Wound Drainage After Knee or Hip Arthroplasty
Condition: Complications; Arthroplasty
Interventions: Drug: Rivaroxaban (Xarelto);   Drug: Warfarin (Coumadin)
37 Recruiting Registry for Estimation of Warfarin and Rivaroxaban in Atrial Fibrillation Patients With Coronary Stent Implantation
Conditions: Coronary Artery Disease;   Atrial Fibrillation;   Stroke;   Fetal Blood Loss
Intervention: Drug: Warfarin or Rivaroxaban
38 Unknown  The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR
Condition: Deep Venous Thromboembolism
Intervention: Drug: warfarin
39 Unknown  VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management
Conditions: Atrial Fibrillation;   Cardiac Thrombus;   Deep Vein Thrombosis;   Pulmonary Embolism;   Heart Valve Replacement (Mechanical or Biological With AF);   Cardiomyopathy (Ischemic or Dilated);   Peripheral Vascular Disease
Intervention: Drug: Warfarin dose titration
40 Not yet recruiting A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam in Patients With ALK-positive Advanced Tumors
Condition: ALK-positive Advanced Tumors
Interventions: Drug: ceritinib;   Drug: warfarin;   Drug: midazolam

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years